- CRS Publications
- News
News
Authors:
Date:
Business Wire: September 26, 2016 – CAMBRIDGE, MA, U.S.A. – Dicerna Pharmaceuticals, Inc. (Nasdaq:DRNA), a leading developer of investigational RNA interference (RNAi) therapeutics, today announced that the company will focus its resources on its proprietary GalXC™ technology platform to advance…
Authors:
Date:
Business Wire: September 20, 2016 – PALM BEACH GARDENS, FL, U.S.A. – Transdermal Delivery Solutions Corporation (TDSC) announced today the signing of a product license arrangement with ALZYN, LLC, of St. Petersburg, Florida.
“We are pleased to announce the finalization of our agreement for this…
Authors:
Date:
Business Wire: September 20, 2016 – NEW YORK, NY and CAMBRIDGE, MA, U.S.A. – Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher and Suono Bio are the winners of…
Authors:
Date:
Business Wire: September 13, 2016 – WOBURN, MA, U.S.A. – Aphios Corporation today announced that it plans to continue its research to develop a cure for HIV/AIDS using combination drugs in targeted “nanosomes” nanoparticles with recent funding from the National Institute of Allergy and Infectious…
Authors:
Date:
Business Wire: September 13, 2016 – SOMERSET, NJ, U.S.A. – Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics, and consumer health products, today announced an agreement for Catalent, through its wholly owned…
Authors:
Date:
PRNewswire: September 8, 2016 – HAYWARD, CA, U.S.A. – Chrono Therapeutics, a pioneer in digital drug therapy and recent recipient of the World Economic Forum Technology Pioneer Award, today announced that it has closed a $47.6 million series B financing. The round was led by Kaiser Permanente…
